
News|Videos|December 6, 2025
Keeping Pace with the Latest Research and Insights
Author(s)Judith Hey-Hadavi, Nicole Snow
Advertisement
Episodes in this series

In this episode, Judith Hey-Hadavi, vice president of Medical Affairs at Worldwide Clinical Trials, and Nicole Snow, Senior Clinical Pharmacy Liaison at Olympia Pharmaceuticals, discuss strategies for staying current in the rapidly evolving GLP-1 therapy landscape. They emphasize the importance of clinical teams monitoring emerging research, clinical trial data, and upcoming therapies to ensure clinicians and patients receive timely, evidence-based guidance. Hey-Hadavi highlights the value of attending conferences and collaborating with pharmaceutical sponsors, while Snow underscores the role of structured internal teams in filtering and communicating relevant insights for patient care.
Advertisement
Related to this article

Liquid chromatography–tandem mass spectrometry (LC–MS/MS) reveals distinct sphingolipid patterns in anorexia and obesity.

Leon Niezen and Gert Desmet discuss uncertainty-driven LC method development, peak overlap, and moving from in silico to real data.

Leon Niezen and Gert Desmet describe how predictive uncertainty can make automated LC method development more reliable.

Liquid chromatography–mass spectrometry (LC–MS) serum profiling ties lysine compounds to lupus kidney disease.

Liquid chromatography-mass spectrometry (LC–MS) growth lifts Waters Q3; MOBILion ion mobility buy expands proteomics.

Liquid chromatography–tandem mass spectrometry (LC–MS/MS) measures galactose-1-phosphate in dried blood spots to monitor galactosemia.
Advertisement
Advertisement
Trending on LCGC International
1
AI/ML Now: Toxicity Prediction for Unknown LC–HRMS Features Using Machine Learning
2
LCGC Blog: Building a Career Series That Goes Beyond the Surface
3
From 9000 Clues to a Clinical Test: Mass Spectrometry-Driven Lipidomics for Early Cancer Detection
4
Testing Plastic Packaging for PFAS Without SPE: A Fast, Cost-Effective Direct Shoot LC-MS/MS Method on the QSight® 500 System That Meets Regulatory Requirements
5








